CN114250215A - 一种超嗜热ii型普鲁兰酶及应用 - Google Patents

一种超嗜热ii型普鲁兰酶及应用 Download PDF

Info

Publication number
CN114250215A
CN114250215A CN202111483679.0A CN202111483679A CN114250215A CN 114250215 A CN114250215 A CN 114250215A CN 202111483679 A CN202111483679 A CN 202111483679A CN 114250215 A CN114250215 A CN 114250215A
Authority
CN
China
Prior art keywords
leu
glu
tyr
gly
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111483679.0A
Other languages
English (en)
Other versions
CN114250215B (zh
Inventor
周哲敏
周丽
谢婷
韩来闯
崔文璟
刘中美
程中一
郭军玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202111483679.0A priority Critical patent/CN114250215B/zh
Publication of CN114250215A publication Critical patent/CN114250215A/zh
Application granted granted Critical
Publication of CN114250215B publication Critical patent/CN114250215B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2451Glucanases acting on alpha-1,6-glucosidic bonds
    • C12N9/2457Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/02Monosaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01041Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C13SUGAR INDUSTRY
    • C13KSACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K1/00Glucose; Glucose-containing syrups
    • C13K1/06Glucose; Glucose-containing syrups obtained by saccharification of starch or raw materials containing starch
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

本发明公开了一种超嗜热II型普鲁兰酶及应用,属于基因工程技术领域。本发明通过对超嗜热II型普鲁兰酶进行氨基酸突变,获得了超嗜热II型普鲁兰酶突变体Q13H、I25E和Q13H/I25E。本发明获得的突变体催化性能有了很大的提高,且突变体在反应过程中不需要其他金属离子辅助(例如Ca2+),有助于降低产物提取成本。本发明构建的突变体具有极强的热稳定性,在100℃保温10h还剩余50%的酶活,并具有较为广泛的pH活性范围和pH耐受性,在pH 5.8‑7.0范围保有70%活性,于不同的pH下,4℃放置剩余酶活均在75%以上,能很好的应用于淀粉工业中的糖化过程中。

Description

一种超嗜热II型普鲁兰酶及应用
技术领域
本发明涉及一种超嗜热II型普鲁兰酶及应用,属于基因工程技术领域。
背景技术
普鲁兰酶(EC 3.2.1.41)是糖苷水解酶家族中最重要的成员之一,通常由多个结构域组成,并且根据水解方式及产物的不同而被分为I型和II型。I型普鲁兰酶只作用于ɑ-1,6糖苷键,可以将淀粉,普鲁兰糖,ɑ-极限糊精等水解为麦芽三糖,线性寡糖。而II型普鲁兰酶是一种双功能酶,可以作用于ɑ-1,6和ɑ-1,4糖苷键,其水解产物是麦芽三糖和葡萄糖。普鲁兰酶在制糖工业(葡萄糖浆和果糖糖浆)、发酵工业(啤酒和有机酸)、饲料、抗性淀粉的制备等具有很好的应用。
在制糖工业中,通常分为两个步骤,首先是淀粉的液化,此步骤是在ɑ-淀粉酶的作用下,条件为95℃,pH 6.0,将淀粉水解为ɑ-环糊精;第二个是糖化,此步骤是普鲁兰酶和糖化酶,在55-60℃pH 4.5-5.0条件下去除支链将ɑ-环糊精彻底水解为葡萄糖。普鲁兰酶和糖化酶的协同作用下能够使淀粉水解的更彻底,提高淀粉的转化率。
在糖化过程中,普鲁兰酶和糖化酶拥有相同的反应条件可以减少工业生产上的消耗,其关键就是最适pH和温度。现有的糖化酶最适pH通常在4.5-5.0范围内,反应温度为60℃左右。目前,报道的超嗜热II型普鲁兰酶的最适pH多数为6.0-6.5,最适温度为80-100℃,并不适应于糖化过程,虽然有一种来源Thermofilum pendens的嗜酸II型普鲁兰酶,最适pH为3.5,但其活性较低的活性,淀粉转化率不高。因此提供一种在pH 4.5-5.0具有高酶活的II型普鲁兰酶在淀粉工业加工上中有重要的应用意义。
发明内容
本发明的第一个目的是提供了一种重组II型普鲁兰酶的突变体,是在SEQ IDNO.1所编码的氨基酸序列的基础上,进行了如下至少一种突变:
(1)将第13位谷氨酰胺突变为组氨酸的得到SEQ ID NO.2氨基酸序列,命名为Q13H;
(2)将第25位异亮氨酸突变为谷氨酸得到SEQ ID NO.3,命名为I25E。
在一种实施方式中,所述突变体是在SEQ ID NO.1所示的氨基酸序列基础上将13位异亮氨酸突变为组氨酸,并将第25位异亮氨酸突变为谷氨酸,得到SEQ ID NO.4编码氨基酸,命名为Q13H/I25E。
本发明还提供了编码所述突变体的基因。
在一种实施方式中,所述基因是在SEQ ID NO.5的基础上,将第13位的密码子由CAG替换为CAT,获得编码突变体Q13H的基因。
在一种实施方式中,所述基因是在SEQ ID NO.5的基础上,将第25位的密码子由ATT替换为GAA,获得编码突变体I25E的基因。
在一种实施方式中,所述基因是在SEQ ID NO.5的基础上,将第25位的密码子由CAG替换为CAT,并将25位的密码子由ATT替换为GAA,获得编码突变体Q13H/I25E的基因。
本发明还提供了携带所述基因的重组质粒。
本发明还提供一种构建II型普鲁兰酶突变体的方法,包括如下步骤:
(1)在II型普鲁兰酶的SEQ ID NO.1所编码氨基酸序列基础上确定需要突变的位点,并设计对应突变位点的引物,以含有II型普鲁兰酶编码的核酸序列的质粒为模板,全质粒PCR获得突变体质粒;
(2)将步骤(1)的突变体质粒在宿主菌株中克隆,诱导表达;
(3)分别纯化II型普鲁兰酶的突变体Q13H、I25E、Q13H/I25E。
本发明还提供了表达所述突变体的重组微生物。
在一种实施方式中,所述重组微生物是重组大肠杆菌。
在一种实施方式中,所述重组大肠杆菌是以大肠杆菌BL21(DE3)为宿主,以pET系列质粒为表达载体。
本发明还提供了一种生产II型普鲁兰酶突变体的方法,是将所述重组大肠杆菌接种至培养基中,于30~37℃培养至OD600达到0.6-0.8,在以终浓度1~3mM IPTG和终浓度为1~3%的无水乙醇于16~20℃诱导16-20h。
在一种实施方式中,所述培养基包括LB培养基或2YT培养基。
本发明还要求保护所述II型普鲁兰酶突变体在制糖工业中的应用。
在一种实施方式中,所述应用是将所述II型普鲁兰酶用于淀粉水解液的糖化。
在一种实施方式中,所述应用是将所述II型普鲁兰酶和糖化酶共同用于淀粉水解液的糖化。
本发明的有益效果:
(1)本发明筛选获得了II型普鲁兰酶的突变体,在反应过程中不需要其他金属离子辅助(例如Ca2+),有助于降低产物提取成本;本发明获得的II型普鲁兰酶突变体具有较为广泛的pH活性范围,并具有低pH耐受性,能很好的应用于淀粉工业中的糖化过程中。
(2)本发明提供的突变体Q13H的最适pH为5.0,比酶活是54.2U/mg,相较于野生型的最大比活(pH 6.4)提高了70%;其催化效率kcat/Km是野生型的3.4倍;并且在pH 4.4、5.0的比酶活是野生型的3.8倍和3倍,同时扩宽了普鲁兰酶的pH活性范围,从原来的5.8-6.8扩大到4.8-7.0。
(3)本发明构建的单点突变体I25E的最适pH为5.5,比酶活是45U/mg,相较于野生型的最大比活(pH 6.4)提高了40%。
(4)本发明构建的迭代组合突变体Q13H/I25E的最适pH为5.0,测定的比活为63.9U/mg,是野生型最大比酶活的2倍,催化效率kcat/Km是野生型的2.9倍;在pH 4.4、5.0的比酶活是野生型的4倍和3.6倍,同时扩宽了普鲁兰酶的pH活性范围,从原来的5.8-6.8扩大到4.8-7.0;并且在100℃保温4h仍剩余70%酶活高于野生型的剩余酶活(50%)。
附图说明
图1为II型普鲁兰酶的突变体在不同pH的比酶活结果。
图2为II型普鲁兰酶及突变体Q13H/I25E在100℃放置不同时间的剩余酶活。
图3为II型普鲁兰酶及突变体Q13H/I25E在不同pH下放置4h剩余酶活。
图4为将II型普鲁兰酶第13位氨基酸突变为不同氨基酸后的突变体的比酶活。
具体实施方式
本发明实施例中的所用一下材料、试剂及培养基:
(一)质粒及菌株
使用pET24a载体克隆表达SEQ ID NO.1编码的基因序列;用于基因克隆的菌株为大肠杆菌JM109;用于表达酶的菌株为大肠杆菌BL21(DE3)。
(二)酶及反应底物
PrimeSTAR MAX DNA及Dpn I消化酶均购自于TAKARA公司,底物普鲁兰糖属于食品级购自于山东福瑞达生物科技有限公司,DNS配制试剂均属国产普通试剂。
(三)试剂和培养基
纯化试剂:1L结合缓溶液:含有125mL磷酸盐缓冲液(50mmol/L Na2HPO4、50mmol/LNaH2PO4、500mmol/L NaCl),10mL 2M咪唑溶液;1L洗脱缓冲液:125mL磷酸盐缓冲液(50mmol/L Na2HPO4、50mmol/L NaH2PO4、500mmol/L NaCl),250mL 2M咪唑溶液;
反应缓冲液:pH为5.8,6.0,6.4,6.8,7.2,7.6,8.0的100mM磷酸钾缓冲液;pH为4.0,4.4,4.8,5.0,5.4,5.8的100mM醋酸钠缓冲液。
LB液体培养基(每L):10g氯化钠,10g蛋白胨,5g酵母粉,1L超纯水。
LB固体培养基(每L):10g氯化钠,10g蛋白胨,5g酵母粉,20g琼脂粉,1L超纯水。
2YT液体培养基(每L):16g蛋白胨,10g酵母粉,5g氯化钠,1L超纯水。
(四)酶活的测定:利用Breadford试剂测定酶活反应体系:40μL普鲁兰酶,6%普鲁兰糖50μL,100mM不同pH缓冲液10uL。首先将缓冲液和底物普鲁兰糖混合在100℃预热5min,然后加入普鲁兰酶于100℃反应15min,反应结束后向反应体系中加入100μL DNS,100℃煮沸6min。最后将反应产物用水稀释72倍,用分光光度计测定OD476下的吸光值,根据葡萄糖做的标曲,计算产物形成量。
酶活定义:在合适的测定条件下,每分钟生成1μmol还原糖所需的酶量为一个U。
实施例1II型普鲁兰酶单突变体的构建
单突变体的制备:根据SEQ ID NO.1所示编码的核苷酸序列基础上,设计单个位点突变的引物,分别设计Q13H和I25E上下游引物,并在金唯智生物公司合成。以带有SEQ IDNO.1编码的基因的质粒为模板,利用快速PCR扩增单点突变序列,测序验证突变基因,从而获得Q13H和I25E单突变体质粒。
组合突变体的制备:在单突变体质粒Q13H基础上设计I25E上下游引物,并以Q13H单突变体质粒为模板,利用快速PCR扩增,测序验证突变基因,从而获得Q13H-I25E突变质粒。
引入突变体引物序列如下:
Q13H定点突变引物为:
Q13H-F:GTTATTATTGTTTGGCATCACCATCAGCCGTA(下划线为定向突变核苷酸序列);
Q13H-R:CATAATAATACGGCTGATGGTGATGCCAAACA(下划线为定向突变核苷酸序列);
I25E定点突变引物为:
I25E-F:GATCCGGTTCAGGGTGAATATACCCGTCCG(下划线为定向突变核苷酸序列);
I25E-R:ACCCACGGACGGGTATATTCACCCTGAACC(下划线为定向突变核苷酸序列);
PCR反应条件:使用Primer Star Max为PCR扩增试剂,98℃预变性3min,接下来进行30个循环(98℃5min解链,55℃30s复性,72℃90s延伸),随后72℃延伸10min,最后4℃保存。扩增好的PCR产物用琼脂糖凝胶电泳进行检测。
实施例2II型普鲁兰酶突变体的发酵及表达纯化
(1)突变体诱导表达
将实施例1经PCR获得的产物用Dpn I酶于37℃消化2-3h,将消化产物转化至大肠杆菌JM109大量克隆,经测序正确的阳性克隆子提取质粒,并转化到大肠杆菌BL21(DE3)感受态,获得突变体表达菌株,分别命名为BL21-PulPy2-Q13H,BL21-PulPy2-I25E,BL21-PulPy2-Q13H/I25E。
用30%甘油于-80℃保存这三个菌株。然后取出甘油菌在含有50mg/mL卡阿霉素的LB平板上划线,37℃培养10h,接下来挑取一单菌株于5mL含有50mg/mL卡那霉素LB培养基,37℃过夜培养,将培养好的菌液按照1%的比例加入100mL 2YT液体培养基中,37℃培养2-3h,OD600达到0.6-0.8,向菌液中加入2mM IPTG和2%无水乙醇,18℃培养16-20h,获得0D600为2-3的细胞培养液。
(2)蛋白纯化
培养好的菌液在4℃离心机12000rpm离心4min,弃去上清,保留菌体。收完菌体之后,向装有菌体的缓冲液中加入一定量的10mM磷酸钾缓冲液,利用超声破碎仪破碎细胞(破碎条件:工作3s,停7s,工作30min),破碎结束后将破碎液在4℃离心机中12000rpm离心30min,保留上清,弃去沉淀。破碎液的上清利用TAKA蛋白纯化仪及HIS trap HP柱纯化出纯净的普鲁兰酶,首先用结合缓冲液平衡HIS柱,然后加入上清,使目的蛋白挂到HIS柱上,再用结合缓冲液冲掉没有挂在柱子的杂蛋白,最后用高浓度咪唑的洗脱缓冲液洗脱目的蛋白,最终获得纯净的普鲁兰酶。
实施例3II型普鲁兰酶及突变体的pH活性范围的测定
将实施例2纯化后的蛋白测定浓度,并把浓度统一调至为100ug/mL,分别在不同pH的缓冲液中测定酶活,结果见图1。
突变体Q13H的最适pH为5.0,比酶活是54.2U/mg,相较于野生型酶在pH 6.4下的最大比酶活提高了1.7倍;其催化效率kcat/Km提高了3.4倍;并且在pH 4.4、5.0下的比酶活相比于野生型分别提高了3.8倍和3倍,扩宽了普鲁兰酶的pH活性范围,从原来的5.8-6.8扩大到4.8-7.0,更适合参与酸性pH下的糖化反应。
另一个单点突变体I25E的最适pH为5.5,比酶活是45U/mg,相较于野生型酶在pH6.4下的最大比酶活提高了1.4倍。迭代组合突变体Q13H/I25E的最适pH为5.0,测定的比酶活为63.9U/mg,并且在pH 4.4、4.8、5.0下的比酶活相比于野生型分别提高了4倍、4倍和3.8倍,表现出在酶活方面有更为明显的提高。
实施例4迭代突变体Q13H/I25E在100℃下的热稳定性测定
(1)100℃热稳定性测定
纯化后的普鲁兰酶及突变体Q13H/I25E浓度均调至100μg/mL,取400μL蛋白与100μL pH 6.5磷酸钾缓冲液混合在2mL离心管中,然后放置100℃,每次实验放置30个2mL,每隔两个小时取出3个离心管放入4℃冰箱中,在100℃分别放置2、4、6、8、10h,然后在每个离心管中加入500μL普鲁兰糖,100℃中反应15min,反应结束后向反应液中加入1000μLDNS,100℃煮沸6min终止反应,最后将反应液用水稀释72倍,测OD476吸光值,计算出剩余酶活,结果如图2。
结果表明在100℃处理240min后,迭代突变体仍保留70%的活性,相较于II型普鲁兰酶的50%有明显的提高,并且在100℃处理600min后,迭代突变体的酶活仍有50%酶活剩余。因此迭代突变体Q13H/I25E在100℃具有较好的热稳定性。
实施例5迭代突变体Q13H/I25E在不同pH下的酶活测定
用10mM不同pH的醋酸钠缓冲液(pH分别为4.0,4.4,4.8,5.0,5.4,5.8)和10mM不同pH的磷酸钾缓冲液(pH分别为5.8,6.0,6.4,6.8,7.2,7.6,8.0),图中pH 5.8是在磷酸钾缓冲液中测定的。将纯化后的蛋白稀释到100μg/mL,然后于4℃放置4h,然后采用上述的酶活测定方法测其剩余酶活。结果如图3。结果表明II型普鲁兰酶及突变体在不同pH中放置4h均能剩余75%以上的酶活,而迭代突变体Q13H/I25E在pH 4-5之间几乎没有活性损失,尤其在pH4.0孵育4h后的剩余酶活相较野生型提高约50%,因此相较于野生型具有较好的pH耐受性。
对比例1:
具体实施方式同实施例1,区别在于,将第13位氨基酸分别突变为亮氨酸、苯丙氨酸、丝氨酸、赖氨酸、丙氨酸,按照实施例2相同方法制备纯化的酶蛋白,测定在pH 5.0,6.4,8.0的比酶活。
结果如图4,突变为这几个氨基酸酶活均没有突变体Q13H、I25E、Q13H/I25E的高,并且这几个突变体在pH6.4的活性均高于pH5.0。
虽然本发明已以较佳实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明的精神和范围内,都可做各种的改动与修饰,因此本发明的保护范围应该以权利要求书所界定的为准。
SEQUENCE LISTING
<110> 江南大学
<120> 一种超嗜热II型普鲁兰酶及应用
<130> BAA211640A
<160> 5
<170> PatentIn version 3.3
<210> 1
<211> 764
<212> PRT
<213> 人工序列
<400> 1
Met Pro Lys Pro Leu Asn Val Ile Ile Val Trp His Gln His Gln Pro
1 5 10 15
Tyr Tyr Tyr Asp Pro Val Gln Gly Ile Tyr Thr Arg Pro Trp Val Arg
20 25 30
Leu His Ala Ala Asn Asn Tyr Trp Lys Met Ala Tyr Tyr Leu Ser Lys
35 40 45
Tyr Pro Asp Val His Ala Thr Ile Asp Leu Ser Gly Ser Leu Ile Ala
50 55 60
Gln Leu Ala Asp Tyr Met Asn Gly Ala Lys Asp Ile Tyr Gln Ile Ile
65 70 75 80
Thr Glu Lys Ile Ala Lys Gly Glu Pro Leu Thr Val Glu Glu Lys Trp
85 90 95
Leu Met Leu Gln Ala Pro Gly Gly Phe Phe Asp His Thr Ile Pro Trp
100 105 110
Asn Gly Glu Pro Val Thr Asp Lys Asn Gly Asn Pro Ile Arg Asp Phe
115 120 125
Trp Asn Arg Tyr Thr Glu Leu Lys Asn Lys Met Leu Gln Ala Lys Ala
130 135 140
Lys Tyr Ala Asn Leu Pro Leu Glu Glu Gln Lys Val Ala Val Thr Asn
145 150 155 160
Glu Phe Thr Glu Gln Asp Tyr Ile Asp Leu Ala Val Leu Phe Asn Leu
165 170 175
Ala Trp Ile Asp Tyr Asn Tyr Ile Met Asn Thr Pro Glu Leu Lys Ala
180 185 190
Leu Tyr Glu Lys Val Asp Glu Gly Gly Tyr Thr Arg Glu Asp Val Arg
195 200 205
Thr Val Leu Lys His Gln Met Trp Leu Leu Asn His Thr Phe Glu Glu
210 215 220
His Glu Lys Ile Asn Leu Leu Leu Gly Asn Gly Asn Val Glu Val Thr
225 230 235 240
Val Val Pro Tyr Ala His Pro Ile Gly Pro Ile Leu Asn Asp Phe Gly
245 250 255
Trp Glu Glu Asp Phe Asp Ala His Val Lys Lys Ala His Glu Leu Tyr
260 265 270
Lys Lys Tyr Leu Gly Ala Gly Lys Val Thr Pro Lys Gly Gly Trp Ala
275 280 285
Ala Glu Ser Ala Leu Asn Asp Lys Thr Leu Glu Ile Leu Ala Glu Asn
290 295 300
Gly Trp Gln Trp Val Met Thr Asp Gln Leu Val Leu Gln Lys Leu Gly
305 310 315 320
Ile Pro Tyr Thr Val Glu Asn Tyr Tyr Lys Pro Trp Val Ala Glu Phe
325 330 335
Asn Gly Arg Lys Ile Tyr Leu Phe Pro Arg Asp His Ala Leu Ser Asp
340 345 350
Arg Val Gly Phe Thr Tyr Ser Gly Met Asn Gln Tyr Gln Ala Val Glu
355 360 365
Asp Phe Ile Asn Glu Leu Leu Arg Ile Gln Lys Gln Asn Tyr Asp Gly
370 375 380
Ser Leu Val Tyr Val Ile Thr Leu Asp Gly Glu Asn Pro Trp Glu His
385 390 395 400
Tyr Pro Tyr Asp Gly Lys Leu Phe Leu Glu Thr Leu Tyr Lys Arg Leu
405 410 415
Thr Glu Leu Gln Arg Gln Gly Leu Ile Arg Thr Leu Thr Pro Ser Glu
420 425 430
Tyr Ile Lys Leu Tyr Gly Asp Lys Ala Asn Lys Leu Thr Pro Gln Met
435 440 445
Met Glu Arg Leu Asp Leu Thr Gly Asp Asn Val Glu Ala Leu Leu Lys
450 455 460
Ala Gln Ser Leu Gly Glu Leu Tyr Asp Met Ile Gly Val Lys Glu Glu
465 470 475 480
Met Gln Trp Pro Glu Ser Ser Trp Ile Asp Gly Thr Leu Ser Thr Trp
485 490 495
Ile Gly Glu Pro Gln Glu Asn Tyr Gly Trp Tyr Trp Leu Tyr Leu Ala
500 505 510
Arg Lys Ala Leu Met Ala Gln Lys Asp Lys Met Ser Gln Glu Asn Trp
515 520 525
Glu Lys Ala Tyr Glu Tyr Leu Leu Arg Ala Glu Ala Ser Asp Trp Phe
530 535 540
Trp Trp Tyr Gly Ser Asp Gln Ser Ser Gly Gln Asp Tyr Thr Phe Asp
545 550 555 560
Arg Tyr Phe Lys Thr Tyr Leu Tyr Glu Ile Tyr Arg Leu Ala Gly Leu
565 570 575
Glu Pro Pro Ser Tyr Leu Tyr Gly Asn Tyr Phe Pro Asp Gly Glu Pro
580 585 590
Tyr Thr Ile Arg Ala Leu Glu Gly Leu Gly Glu Gly Gln Val Lys Glu
595 600 605
Tyr Ser Ser Met Ser Pro Leu Ala Glu Gly Val Ser Val Tyr Phe Asp
610 615 620
Gly Glu Gly Val His Phe Val Val Lys Gly Asn Leu Glu Lys Phe Glu
625 630 635 640
Ile Ser Ile Tyr Glu Lys Gly Glu Arg Val Gly Asn Thr Phe Thr Leu
645 650 655
Leu Gln Glu Arg Pro Gly Glu Leu Lys Tyr Ser Leu Phe Pro Phe Ser
660 665 670
Arg Asp Ser Val Gly Leu Leu Ile Pro Ile Thr Lys His Val Val Tyr
675 680 685
Arg Asp Gly Lys Ala Glu Ile Tyr Ala Ala Thr Asp Tyr Glu Asn Thr
690 695 700
Glu Lys Val Gly Glu Ala Ser Val Lys Gln Val Asp Gly Gly Val Glu
705 710 715 720
Ile Val Val Pro Phe Asp Tyr Ile Lys Thr Pro Glu Asp Phe Tyr Phe
725 730 735
Ala Val Ser Thr Val Lys Asp Gly Glu Leu Glu Ile Ile Thr Thr Pro
740 745 750
Ile Glu Leu Lys Leu Pro Met Glu Val Lys Gly Val
755 760
<210> 2
<211> 764
<212> PRT
<213> 人工序列
<400> 2
Met Pro Lys Pro Leu Asn Val Ile Ile Val Trp His His His Gln Pro
1 5 10 15
Tyr Tyr Tyr Asp Pro Val Gln Gly Ile Tyr Thr Arg Pro Trp Val Arg
20 25 30
Leu His Ala Ala Asn Asn Tyr Trp Lys Met Ala Tyr Tyr Leu Ser Lys
35 40 45
Tyr Pro Asp Val His Ala Thr Ile Asp Leu Ser Gly Ser Leu Ile Ala
50 55 60
Gln Leu Ala Asp Tyr Met Asn Gly Ala Lys Asp Ile Tyr Gln Ile Ile
65 70 75 80
Thr Glu Lys Ile Ala Lys Gly Glu Pro Leu Thr Val Glu Glu Lys Trp
85 90 95
Leu Met Leu Gln Ala Pro Gly Gly Phe Phe Asp His Thr Ile Pro Trp
100 105 110
Asn Gly Glu Pro Val Thr Asp Lys Asn Gly Asn Pro Ile Arg Asp Phe
115 120 125
Trp Asn Arg Tyr Thr Glu Leu Lys Asn Lys Met Leu Gln Ala Lys Ala
130 135 140
Lys Tyr Ala Asn Leu Pro Leu Glu Glu Gln Lys Val Ala Val Thr Asn
145 150 155 160
Glu Phe Thr Glu Gln Asp Tyr Ile Asp Leu Ala Val Leu Phe Asn Leu
165 170 175
Ala Trp Ile Asp Tyr Asn Tyr Ile Met Asn Thr Pro Glu Leu Lys Ala
180 185 190
Leu Tyr Glu Lys Val Asp Glu Gly Gly Tyr Thr Arg Glu Asp Val Arg
195 200 205
Thr Val Leu Lys His Gln Met Trp Leu Leu Asn His Thr Phe Glu Glu
210 215 220
His Glu Lys Ile Asn Leu Leu Leu Gly Asn Gly Asn Val Glu Val Thr
225 230 235 240
Val Val Pro Tyr Ala His Pro Ile Gly Pro Ile Leu Asn Asp Phe Gly
245 250 255
Trp Glu Glu Asp Phe Asp Ala His Val Lys Lys Ala His Glu Leu Tyr
260 265 270
Lys Lys Tyr Leu Gly Ala Gly Lys Val Thr Pro Lys Gly Gly Trp Ala
275 280 285
Ala Glu Ser Ala Leu Asn Asp Lys Thr Leu Glu Ile Leu Ala Glu Asn
290 295 300
Gly Trp Gln Trp Val Met Thr Asp Gln Leu Val Leu Gln Lys Leu Gly
305 310 315 320
Ile Pro Tyr Thr Val Glu Asn Tyr Tyr Lys Pro Trp Val Ala Glu Phe
325 330 335
Asn Gly Arg Lys Ile Tyr Leu Phe Pro Arg Asp His Ala Leu Ser Asp
340 345 350
Arg Val Gly Phe Thr Tyr Ser Gly Met Asn Gln Tyr Gln Ala Val Glu
355 360 365
Asp Phe Ile Asn Glu Leu Leu Arg Ile Gln Lys Gln Asn Tyr Asp Gly
370 375 380
Ser Leu Val Tyr Val Ile Thr Leu Asp Gly Glu Asn Pro Trp Glu His
385 390 395 400
Tyr Pro Tyr Asp Gly Lys Leu Phe Leu Glu Thr Leu Tyr Lys Arg Leu
405 410 415
Thr Glu Leu Gln Arg Gln Gly Leu Ile Arg Thr Leu Thr Pro Ser Glu
420 425 430
Tyr Ile Lys Leu Tyr Gly Asp Lys Ala Asn Lys Leu Thr Pro Gln Met
435 440 445
Met Glu Arg Leu Asp Leu Thr Gly Asp Asn Val Glu Ala Leu Leu Lys
450 455 460
Ala Gln Ser Leu Gly Glu Leu Tyr Asp Met Ile Gly Val Lys Glu Glu
465 470 475 480
Met Gln Trp Pro Glu Ser Ser Trp Ile Asp Gly Thr Leu Ser Thr Trp
485 490 495
Ile Gly Glu Pro Gln Glu Asn Tyr Gly Trp Tyr Trp Leu Tyr Leu Ala
500 505 510
Arg Lys Ala Leu Met Ala Gln Lys Asp Lys Met Ser Gln Glu Asn Trp
515 520 525
Glu Lys Ala Tyr Glu Tyr Leu Leu Arg Ala Glu Ala Ser Asp Trp Phe
530 535 540
Trp Trp Tyr Gly Ser Asp Gln Ser Ser Gly Gln Asp Tyr Thr Phe Asp
545 550 555 560
Arg Tyr Phe Lys Thr Tyr Leu Tyr Glu Ile Tyr Arg Leu Ala Gly Leu
565 570 575
Glu Pro Pro Ser Tyr Leu Tyr Gly Asn Tyr Phe Pro Asp Gly Glu Pro
580 585 590
Tyr Thr Ile Arg Ala Leu Glu Gly Leu Gly Glu Gly Gln Val Lys Glu
595 600 605
Tyr Ser Ser Met Ser Pro Leu Ala Glu Gly Val Ser Val Tyr Phe Asp
610 615 620
Gly Glu Gly Val His Phe Val Val Lys Gly Asn Leu Glu Lys Phe Glu
625 630 635 640
Ile Ser Ile Tyr Glu Lys Gly Glu Arg Val Gly Asn Thr Phe Thr Leu
645 650 655
Leu Gln Glu Arg Pro Gly Glu Leu Lys Tyr Ser Leu Phe Pro Phe Ser
660 665 670
Arg Asp Ser Val Gly Leu Leu Ile Pro Ile Thr Lys His Val Val Tyr
675 680 685
Arg Asp Gly Lys Ala Glu Ile Tyr Ala Ala Thr Asp Tyr Glu Asn Thr
690 695 700
Glu Lys Val Gly Glu Ala Ser Val Lys Gln Val Asp Gly Gly Val Glu
705 710 715 720
Ile Val Val Pro Phe Asp Tyr Ile Lys Thr Pro Glu Asp Phe Tyr Phe
725 730 735
Ala Val Ser Thr Val Lys Asp Gly Glu Leu Glu Ile Ile Thr Thr Pro
740 745 750
Ile Glu Leu Lys Leu Pro Met Glu Val Lys Gly Val
755 760
<210> 3
<211> 764
<212> PRT
<213> 人工序列
<400> 3
Met Pro Lys Pro Leu Asn Val Ile Ile Val Trp His Gln His Gln Pro
1 5 10 15
Tyr Tyr Tyr Asp Pro Val Gln Gly Glu Tyr Thr Arg Pro Trp Val Arg
20 25 30
Leu His Ala Ala Asn Asn Tyr Trp Lys Met Ala Tyr Tyr Leu Ser Lys
35 40 45
Tyr Pro Asp Val His Ala Thr Ile Asp Leu Ser Gly Ser Leu Ile Ala
50 55 60
Gln Leu Ala Asp Tyr Met Asn Gly Ala Lys Asp Ile Tyr Gln Ile Ile
65 70 75 80
Thr Glu Lys Ile Ala Lys Gly Glu Pro Leu Thr Val Glu Glu Lys Trp
85 90 95
Leu Met Leu Gln Ala Pro Gly Gly Phe Phe Asp His Thr Ile Pro Trp
100 105 110
Asn Gly Glu Pro Val Thr Asp Lys Asn Gly Asn Pro Ile Arg Asp Phe
115 120 125
Trp Asn Arg Tyr Thr Glu Leu Lys Asn Lys Met Leu Gln Ala Lys Ala
130 135 140
Lys Tyr Ala Asn Leu Pro Leu Glu Glu Gln Lys Val Ala Val Thr Asn
145 150 155 160
Glu Phe Thr Glu Gln Asp Tyr Ile Asp Leu Ala Val Leu Phe Asn Leu
165 170 175
Ala Trp Ile Asp Tyr Asn Tyr Ile Met Asn Thr Pro Glu Leu Lys Ala
180 185 190
Leu Tyr Glu Lys Val Asp Glu Gly Gly Tyr Thr Arg Glu Asp Val Arg
195 200 205
Thr Val Leu Lys His Gln Met Trp Leu Leu Asn His Thr Phe Glu Glu
210 215 220
His Glu Lys Ile Asn Leu Leu Leu Gly Asn Gly Asn Val Glu Val Thr
225 230 235 240
Val Val Pro Tyr Ala His Pro Ile Gly Pro Ile Leu Asn Asp Phe Gly
245 250 255
Trp Glu Glu Asp Phe Asp Ala His Val Lys Lys Ala His Glu Leu Tyr
260 265 270
Lys Lys Tyr Leu Gly Ala Gly Lys Val Thr Pro Lys Gly Gly Trp Ala
275 280 285
Ala Glu Ser Ala Leu Asn Asp Lys Thr Leu Glu Ile Leu Ala Glu Asn
290 295 300
Gly Trp Gln Trp Val Met Thr Asp Gln Leu Val Leu Gln Lys Leu Gly
305 310 315 320
Ile Pro Tyr Thr Val Glu Asn Tyr Tyr Lys Pro Trp Val Ala Glu Phe
325 330 335
Asn Gly Arg Lys Ile Tyr Leu Phe Pro Arg Asp His Ala Leu Ser Asp
340 345 350
Arg Val Gly Phe Thr Tyr Ser Gly Met Asn Gln Tyr Gln Ala Val Glu
355 360 365
Asp Phe Ile Asn Glu Leu Leu Arg Ile Gln Lys Gln Asn Tyr Asp Gly
370 375 380
Ser Leu Val Tyr Val Ile Thr Leu Asp Gly Glu Asn Pro Trp Glu His
385 390 395 400
Tyr Pro Tyr Asp Gly Lys Leu Phe Leu Glu Thr Leu Tyr Lys Arg Leu
405 410 415
Thr Glu Leu Gln Arg Gln Gly Leu Ile Arg Thr Leu Thr Pro Ser Glu
420 425 430
Tyr Ile Lys Leu Tyr Gly Asp Lys Ala Asn Lys Leu Thr Pro Gln Met
435 440 445
Met Glu Arg Leu Asp Leu Thr Gly Asp Asn Val Glu Ala Leu Leu Lys
450 455 460
Ala Gln Ser Leu Gly Glu Leu Tyr Asp Met Ile Gly Val Lys Glu Glu
465 470 475 480
Met Gln Trp Pro Glu Ser Ser Trp Ile Asp Gly Thr Leu Ser Thr Trp
485 490 495
Ile Gly Glu Pro Gln Glu Asn Tyr Gly Trp Tyr Trp Leu Tyr Leu Ala
500 505 510
Arg Lys Ala Leu Met Ala Gln Lys Asp Lys Met Ser Gln Glu Asn Trp
515 520 525
Glu Lys Ala Tyr Glu Tyr Leu Leu Arg Ala Glu Ala Ser Asp Trp Phe
530 535 540
Trp Trp Tyr Gly Ser Asp Gln Ser Ser Gly Gln Asp Tyr Thr Phe Asp
545 550 555 560
Arg Tyr Phe Lys Thr Tyr Leu Tyr Glu Ile Tyr Arg Leu Ala Gly Leu
565 570 575
Glu Pro Pro Ser Tyr Leu Tyr Gly Asn Tyr Phe Pro Asp Gly Glu Pro
580 585 590
Tyr Thr Ile Arg Ala Leu Glu Gly Leu Gly Glu Gly Gln Val Lys Glu
595 600 605
Tyr Ser Ser Met Ser Pro Leu Ala Glu Gly Val Ser Val Tyr Phe Asp
610 615 620
Gly Glu Gly Val His Phe Val Val Lys Gly Asn Leu Glu Lys Phe Glu
625 630 635 640
Ile Ser Ile Tyr Glu Lys Gly Glu Arg Val Gly Asn Thr Phe Thr Leu
645 650 655
Leu Gln Glu Arg Pro Gly Glu Leu Lys Tyr Ser Leu Phe Pro Phe Ser
660 665 670
Arg Asp Ser Val Gly Leu Leu Ile Pro Ile Thr Lys His Val Val Tyr
675 680 685
Arg Asp Gly Lys Ala Glu Ile Tyr Ala Ala Thr Asp Tyr Glu Asn Thr
690 695 700
Glu Lys Val Gly Glu Ala Ser Val Lys Gln Val Asp Gly Gly Val Glu
705 710 715 720
Ile Val Val Pro Phe Asp Tyr Ile Lys Thr Pro Glu Asp Phe Tyr Phe
725 730 735
Ala Val Ser Thr Val Lys Asp Gly Glu Leu Glu Ile Ile Thr Thr Pro
740 745 750
Ile Glu Leu Lys Leu Pro Met Glu Val Lys Gly Val
755 760
<210> 4
<211> 764
<212> PRT
<213> 人工序列
<400> 4
Met Pro Lys Pro Leu Asn Val Ile Ile Val Trp His His His Gln Pro
1 5 10 15
Tyr Tyr Tyr Asp Pro Val Gln Gly Glu Tyr Thr Arg Pro Trp Val Arg
20 25 30
Leu His Ala Ala Asn Asn Tyr Trp Lys Met Ala Tyr Tyr Leu Ser Lys
35 40 45
Tyr Pro Asp Val His Ala Thr Ile Asp Leu Ser Gly Ser Leu Ile Ala
50 55 60
Gln Leu Ala Asp Tyr Met Asn Gly Ala Lys Asp Ile Tyr Gln Ile Ile
65 70 75 80
Thr Glu Lys Ile Ala Lys Gly Glu Pro Leu Thr Val Glu Glu Lys Trp
85 90 95
Leu Met Leu Gln Ala Pro Gly Gly Phe Phe Asp His Thr Ile Pro Trp
100 105 110
Asn Gly Glu Pro Val Thr Asp Lys Asn Gly Asn Pro Ile Arg Asp Phe
115 120 125
Trp Asn Arg Tyr Thr Glu Leu Lys Asn Lys Met Leu Gln Ala Lys Ala
130 135 140
Lys Tyr Ala Asn Leu Pro Leu Glu Glu Gln Lys Val Ala Val Thr Asn
145 150 155 160
Glu Phe Thr Glu Gln Asp Tyr Ile Asp Leu Ala Val Leu Phe Asn Leu
165 170 175
Ala Trp Ile Asp Tyr Asn Tyr Ile Met Asn Thr Pro Glu Leu Lys Ala
180 185 190
Leu Tyr Glu Lys Val Asp Glu Gly Gly Tyr Thr Arg Glu Asp Val Arg
195 200 205
Thr Val Leu Lys His Gln Met Trp Leu Leu Asn His Thr Phe Glu Glu
210 215 220
His Glu Lys Ile Asn Leu Leu Leu Gly Asn Gly Asn Val Glu Val Thr
225 230 235 240
Val Val Pro Tyr Ala His Pro Ile Gly Pro Ile Leu Asn Asp Phe Gly
245 250 255
Trp Glu Glu Asp Phe Asp Ala His Val Lys Lys Ala His Glu Leu Tyr
260 265 270
Lys Lys Tyr Leu Gly Ala Gly Lys Val Thr Pro Lys Gly Gly Trp Ala
275 280 285
Ala Glu Ser Ala Leu Asn Asp Lys Thr Leu Glu Ile Leu Ala Glu Asn
290 295 300
Gly Trp Gln Trp Val Met Thr Asp Gln Leu Val Leu Gln Lys Leu Gly
305 310 315 320
Ile Pro Tyr Thr Val Glu Asn Tyr Tyr Lys Pro Trp Val Ala Glu Phe
325 330 335
Asn Gly Arg Lys Ile Tyr Leu Phe Pro Arg Asp His Ala Leu Ser Asp
340 345 350
Arg Val Gly Phe Thr Tyr Ser Gly Met Asn Gln Tyr Gln Ala Val Glu
355 360 365
Asp Phe Ile Asn Glu Leu Leu Arg Ile Gln Lys Gln Asn Tyr Asp Gly
370 375 380
Ser Leu Val Tyr Val Ile Thr Leu Asp Gly Glu Asn Pro Trp Glu His
385 390 395 400
Tyr Pro Tyr Asp Gly Lys Leu Phe Leu Glu Thr Leu Tyr Lys Arg Leu
405 410 415
Thr Glu Leu Gln Arg Gln Gly Leu Ile Arg Thr Leu Thr Pro Ser Glu
420 425 430
Tyr Ile Lys Leu Tyr Gly Asp Lys Ala Asn Lys Leu Thr Pro Gln Met
435 440 445
Met Glu Arg Leu Asp Leu Thr Gly Asp Asn Val Glu Ala Leu Leu Lys
450 455 460
Ala Gln Ser Leu Gly Glu Leu Tyr Asp Met Ile Gly Val Lys Glu Glu
465 470 475 480
Met Gln Trp Pro Glu Ser Ser Trp Ile Asp Gly Thr Leu Ser Thr Trp
485 490 495
Ile Gly Glu Pro Gln Glu Asn Tyr Gly Trp Tyr Trp Leu Tyr Leu Ala
500 505 510
Arg Lys Ala Leu Met Ala Gln Lys Asp Lys Met Ser Gln Glu Asn Trp
515 520 525
Glu Lys Ala Tyr Glu Tyr Leu Leu Arg Ala Glu Ala Ser Asp Trp Phe
530 535 540
Trp Trp Tyr Gly Ser Asp Gln Ser Ser Gly Gln Asp Tyr Thr Phe Asp
545 550 555 560
Arg Tyr Phe Lys Thr Tyr Leu Tyr Glu Ile Tyr Arg Leu Ala Gly Leu
565 570 575
Glu Pro Pro Ser Tyr Leu Tyr Gly Asn Tyr Phe Pro Asp Gly Glu Pro
580 585 590
Tyr Thr Ile Arg Ala Leu Glu Gly Leu Gly Glu Gly Gln Val Lys Glu
595 600 605
Tyr Ser Ser Met Ser Pro Leu Ala Glu Gly Val Ser Val Tyr Phe Asp
610 615 620
Gly Glu Gly Val His Phe Val Val Lys Gly Asn Leu Glu Lys Phe Glu
625 630 635 640
Ile Ser Ile Tyr Glu Lys Gly Glu Arg Val Gly Asn Thr Phe Thr Leu
645 650 655
Leu Gln Glu Arg Pro Gly Glu Leu Lys Tyr Ser Leu Phe Pro Phe Ser
660 665 670
Arg Asp Ser Val Gly Leu Leu Ile Pro Ile Thr Lys His Val Val Tyr
675 680 685
Arg Asp Gly Lys Ala Glu Ile Tyr Ala Ala Thr Asp Tyr Glu Asn Thr
690 695 700
Glu Lys Val Gly Glu Ala Ser Val Lys Gln Val Asp Gly Gly Val Glu
705 710 715 720
Ile Val Val Pro Phe Asp Tyr Ile Lys Thr Pro Glu Asp Phe Tyr Phe
725 730 735
Ala Val Ser Thr Val Lys Asp Gly Glu Leu Glu Ile Ile Thr Thr Pro
740 745 750
Ile Glu Leu Lys Leu Pro Met Glu Val Lys Gly Val
755 760
<210> 5
<211> 2289
<212> DNA
<213> 人工序列
<400> 5
atgccgaaac cgctgaatgt tattattgtt tggcatcagc atcagccgta ttattatgat 60
ccggttcagg gtatttatac ccgtccgtgg gttcgtctgc atgcagcaaa taattattgg 120
aaaatggcat attatctgag caaatatccg gatgttcatg caaccattga tctgagcggt 180
agcctgattg cacagctggc agattatatg aatggtgcaa aagatattta tcagatcatc 240
accgaaaaaa tcgcaaaagg tgaaccgctg accgttgaag aaaaatggct gatgctgcag 300
gcaccgggtg gtttttttga tcataccatt ccgtggaatg gtgaaccggt taccgataaa 360
aatggtaatc cgattcgtga tttttggaat cgttataccg aactgaaaaa taaaatgctg 420
caggcaaaag caaaatatgc aaatctgccg ctggaagaac agaaagttgc agttaccaat 480
gaatttaccg aacaggatta tattgacctg gcagttctgt ttaatctggc atggattgat 540
tataattaca tcatgaacac cccggaactg aaagcactgt atgaaaaagt tgatgaaggt 600
ggttataccc gtgaagatgt tcgtaccgtt ctgaaacatc agatgtggct gctgaatcat 660
acctttgaag aacatgaaaa aatcaacctg ctgctgggta atggtaatgt tgaagttacc 720
gttgttccgt atgcacatcc gattggtccg attctgaatg attttggttg ggaagaagat 780
tttgatgcac atgttaaaaa agcacatgaa ctgtataaaa aatacctggg tgcaggtaaa 840
gttaccccga aaggtggttg ggcagcagaa agcgcactga atgataaaac cctggaaatt 900
ctggcagaaa atggttggca gtgggttatg accgatcagc tggttctgca gaaactgggt 960
attccgtata ccgttgaaaa ttattataaa ccgtgggttg cagaatttaa tggtcgtaaa 1020
atttacctgt tcccgcgtga tcatgcactg agcgatcgtg ttggttttac ctatagcggt 1080
atgaatcagt atcaggcagt tgaagatttt attaatgagc tgctgcgtat tcagaaacag 1140
aattatgatg gtagcctggt ttatgttatt accctggatg gtgaaaatcc gtgggaacat 1200
tatccgtatg atggtaaact gtttctggaa accctgtata aacgtctgac cgaactgcag 1260
cgtcagggtc tgattcgtac cctgaccccg agcgaatata ttaaactgta tggtgataaa 1320
gccaacaaac tgaccccgca gatgatggaa cgtctggatc tgaccggtga taatgttgaa 1380
gcactgctga aagcacagag cctgggtgaa ctgtatgata tgattggtgt taaagaagaa 1440
atgcagtggc cggaaagcag ctggattgat ggtacactga gcacctggat tggtgaaccg 1500
caggaaaatt atggttggta ttggctgtat ctggcacgta aagcactgat ggcacagaaa 1560
gataaaatga gccaggaaaa ttgggaaaaa gcatacgaat atctgctgcg tgcagaagca 1620
agcgattggt tttggtggta tggtagcgat cagagcagcg gtcaggatta tacctttgat 1680
cgttatttta aaacctacct gtacgaaatt taccgtctgg caggtctgga accgccgagc 1740
tatctgtatg gtaattattt tccggatggt gaaccgtata ccattcgtgc actggaaggt 1800
ctgggtgaag gtcaggttaa agaatatagc agcatgagcc cgctggcaga aggtgttagc 1860
gtttattttg atggtgaagg tgttcatttt gttgttaaag gtaatctgga aaaattcgaa 1920
atcagcattt acgaaaaagg tgaacgtgtt ggtaatacct ttaccctgct gcaggaacgt 1980
ccgggtgaac tgaaatatag cctgtttccg tttagccgtg atagcgttgg tctgctgatt 2040
accaaacatg ttgtttatcg tgatggtaaa gcagaaattt atgcagcaac cgattatgaa 2100
aataccgaaa aagttggtga agcaagcgtt aaacaggttg atggtggtgt tgaaattgtt 2160
gttccgtttg attatatcaa aaccccggaa gatttttatt tcgcagttag caccgttaaa 2220
gatggtgaac tggaaattat taccaccccg attgaactga aactgccgat ggaagttaaa 2280
ggtgttccg 2289

Claims (10)

1.一种超嗜热II型普鲁兰酶突变体,其特征在于,所述突变体是在SEQ ID NO.1所示的氨基酸序列的基础上,进行了如下至少一种突变:
(1)将第13位谷氨酰胺突变为组氨酸;
(2)将第25位异亮氨酸突变为谷氨酸。
2.编码权利要求1所述超嗜热II型普鲁兰酶突变体的基因。
3.携带权利要求2所述基因的质粒。
4.表达权利要求1所述超嗜热II型普鲁兰酶突变体的重组微生物细胞。
5.一种重组大肠杆菌,其特征在于,以pET系列质粒为表达载体,表达权利要求1所述的超嗜热II型普鲁兰酶突变体。
6.根据权利要求5所述的重组大肠杆菌,其特征在于,以大肠杆菌BL21(DE3)为宿主。
7.一种生产权利要求1所述超嗜热II型普鲁兰酶突变体的方法,其特征在于,将权利要求5或6所述的重组大肠杆菌在培养基中培养,收集培养获得的超嗜热II型普鲁兰酶突变体。
8.根据权利要求7所述的方法,其特征在于,将所述重组大肠杆菌接种至LB培养基中,于30~37℃培养至OD600达到0.6-0.8,在以终浓度1~3mM IPTG和终浓度为1~3%的无水乙醇于16~20℃诱导16-20h。
9.含有权利要求1所述超嗜热II型普鲁兰酶突变体的酶制剂。
10.权利要求1所述II型普鲁兰酶突变体在制糖工业中的应用。
CN202111483679.0A 2021-12-07 2021-12-07 一种超嗜热ii型普鲁兰酶及应用 Active CN114250215B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111483679.0A CN114250215B (zh) 2021-12-07 2021-12-07 一种超嗜热ii型普鲁兰酶及应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111483679.0A CN114250215B (zh) 2021-12-07 2021-12-07 一种超嗜热ii型普鲁兰酶及应用

Publications (2)

Publication Number Publication Date
CN114250215A true CN114250215A (zh) 2022-03-29
CN114250215B CN114250215B (zh) 2023-07-18

Family

ID=80794122

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111483679.0A Active CN114250215B (zh) 2021-12-07 2021-12-07 一种超嗜热ii型普鲁兰酶及应用

Country Status (1)

Country Link
CN (1) CN114250215B (zh)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108660145A (zh) * 2018-07-05 2018-10-16 华东理工大学 耐热型普鲁兰酶的编码基因及其重组表达和应用
CN109355276A (zh) * 2018-11-27 2019-02-19 江南大学 一种普鲁兰酶突变体及其应用
CN109880783A (zh) * 2019-04-19 2019-06-14 江南大学 一种嗜热重组ii型普鲁兰酶及其应用
CN113265386A (zh) * 2021-05-14 2021-08-17 宿迁市江南大学产业技术研究院 一种耐热型中性普鲁兰酶的突变体及其应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108660145A (zh) * 2018-07-05 2018-10-16 华东理工大学 耐热型普鲁兰酶的编码基因及其重组表达和应用
CN109355276A (zh) * 2018-11-27 2019-02-19 江南大学 一种普鲁兰酶突变体及其应用
CN109880783A (zh) * 2019-04-19 2019-06-14 江南大学 一种嗜热重组ii型普鲁兰酶及其应用
CN113265386A (zh) * 2021-05-14 2021-08-17 宿迁市江南大学产业技术研究院 一种耐热型中性普鲁兰酶的突变体及其应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XIE T ET AL.: "Modulating the pH profile of the pullulanase from Pyrococcus yayanosii CH1 by synergistically engineering the active center and surface", 《INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES》, vol. 216, pages 132 - 139, XP087149571, DOI: 10.1016/j.ijbiomac.2022.06.151 *

Also Published As

Publication number Publication date
CN114250215B (zh) 2023-07-18

Similar Documents

Publication Publication Date Title
CN108559735B (zh) 一种亮氨酸脱氢酶突变体的构建及其应用
CN110066777B (zh) 一种内切菊粉酶及其在生产低聚果糖中的应用
CN112391365B (zh) 一种催化活力提高的淀粉分支酶突变体及其应用
CN113862233B (zh) 提高葡萄糖氧化酶的酸稳定性的方法及突变体q241e/r499e、基因和应用
CN106811451B (zh) 一种低温壳聚糖酶及其编码基因与应用
CN112301012B (zh) 一种环糊精葡萄糖基转移酶突变体及其构建方法
CN106801046B (zh) 热稳定性提高的酸性普鲁兰酶突变体及其编码基因和应用
CN116410960A (zh) 嗜盐适冷及pH适应性改良的β-木糖苷酶突变体D41G及其应用
CN112626053B (zh) 一种酸性α淀粉酶及其制备方法与应用
CN113234705B (zh) 耐酸1,3-1,4-β-葡聚糖酶突变体
CN106520733B (zh) 一种β-木糖苷酶体内酶聚集体及其制备方法
CN113151212A (zh) 一种右旋糖酐蔗糖酶及其制备方法和应用
CN114807099B (zh) 普鲁兰酶突变体、工程菌及其应用
CN107164346A (zh) 一种碱性耐盐普鲁兰酶PulA及其基因和应用
CN114250215B (zh) 一种超嗜热ii型普鲁兰酶及应用
CN110951803A (zh) 组合利用特异性琼胶酶制备高纯度新琼二糖的方法及应用
CN114836406A (zh) 一种催化活力提高的琼胶酶突变体及其应用
CN113528487B (zh) 一种通过迭代饱和突变提高木聚糖酶热稳定性的方法
CN109762798A (zh) 一种巴伦葛兹类芽孢杆菌壳聚糖酶的制备方法与应用
CN112210544B (zh) 一种环糊精葡萄糖基转移酶突变体及其应用
CN111961657B (zh) 具有高耐热性的α-淀粉酶突变体K152H/A166C/E168H及其基因和应用
CN114395543B (zh) 一种海藻糖合酶突变体及其应用
CN112831511B (zh) 一种外切褐藻胶裂解酶、其编码基因及应用
CN113528491B (zh) 一种n-糖基化修饰提高黑曲霉木聚糖酶热稳定性的方法
CN113307885B (zh) 一种产物特异性提高的融合蛋白及其制备直链麦芽五糖的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant